Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | histone deacetylase 3 | 0.0062 | 1 | 1 |
Trichomonas vaginalis | histone deacetylase, putative | 0.0062 | 1 | 0.5 |
Echinococcus granulosus | histone deacetylase 3 | 0.0062 | 1 | 1 |
Echinococcus multilocularis | calcium activated potassium channel | 0.0046 | 0.6285 | 0.6285 |
Leishmania major | histone deacetylase, putative | 0.0062 | 1 | 1 |
Loa Loa (eye worm) | histone deacetylase 3 | 0.0062 | 1 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.004 | 0.4904 | 0.4904 |
Trichomonas vaginalis | histone deacetylase, putative | 0.0062 | 1 | 0.5 |
Toxoplasma gondii | histone deacetylase HDAC3 | 0.0062 | 1 | 1 |
Trichomonas vaginalis | histone deacetylase 1, 2 ,3, putative | 0.0062 | 1 | 0.5 |
Brugia malayi | Histone deacetylase 1 | 0.0062 | 1 | 1 |
Schistosoma mansoni | calcium-activated potassium channel | 0.0043 | 0.5565 | 0.5565 |
Trypanosoma brucei | histone deacetylase 1 | 0.0062 | 1 | 1 |
Brugia malayi | histone deacetylase 1 (HD1) | 0.0062 | 1 | 1 |
Giardia lamblia | Histone deacetylase | 0.0062 | 1 | 0.5 |
Brugia malayi | hypothetical protein | 0.004 | 0.4904 | 0.4904 |
Echinococcus multilocularis | calcium activated potassium channel variant | 0.0043 | 0.5565 | 0.5565 |
Schistosoma mansoni | histone deacetylase | 0.0062 | 1 | 1 |
Trichomonas vaginalis | histone deacetylase 1, 2 ,3, putative | 0.0062 | 1 | 0.5 |
Plasmodium vivax | histone deacetylase 1, putative | 0.0062 | 1 | 1 |
Trichomonas vaginalis | histone deacetylase, putative | 0.0062 | 1 | 0.5 |
Trichomonas vaginalis | histone deacetylase, putative | 0.0062 | 1 | 0.5 |
Trypanosoma cruzi | histone deacetylase 1, putative | 0.0062 | 1 | 1 |
Entamoeba histolytica | histone deacetylase, putative | 0.0062 | 1 | 1 |
Echinococcus multilocularis | histone deacetylase 1 | 0.0062 | 1 | 1 |
Toxoplasma gondii | histone deacetylase HDAC2 | 0.0062 | 1 | 1 |
Trichomonas vaginalis | histone deacetylase, putative | 0.0062 | 1 | 0.5 |
Echinococcus granulosus | histone deacetylase 1 | 0.0062 | 1 | 1 |
Echinococcus multilocularis | potassium large conductance calcium activated | 0.0046 | 0.6285 | 0.6285 |
Schistosoma mansoni | histone deacetylase | 0.0062 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.2834 | 0.2834 |
Trichomonas vaginalis | histone deacetylase 1, 2 ,3, putative | 0.0062 | 1 | 0.5 |
Loa Loa (eye worm) | histone deacetylase 1 | 0.0062 | 1 | 1 |
Echinococcus granulosus | calcium activated potassium channel variant | 0.0043 | 0.5565 | 0.5565 |
Loa Loa (eye worm) | hypothetical protein | 0.0062 | 1 | 1 |
Echinococcus granulosus | potassium large conductance calcium activated | 0.0046 | 0.6285 | 0.6285 |
Schistosoma mansoni | calcium-activated potassium channel | 0.0046 | 0.6285 | 0.6285 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.004 | 0.4904 | 0.4904 |
Brugia malayi | Large-conductance calcium-activated potassium channel Slo-1 (KCNMA) alpha subunit. C. elegans slo-1 ortholog | 0.003 | 0.2834 | 0.2834 |
Trichomonas vaginalis | histone deacetylase, putative | 0.0062 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.004 | 0.4904 | 0.4904 |
Leishmania major | histone deacetylase, putative | 0.0062 | 1 | 1 |
Loa Loa (eye worm) | large conductance calcium-activated potassium channel alpha subunit ai | 0.0043 | 0.5565 | 0.5565 |
Echinococcus granulosus | calcium activated potassium channel | 0.0046 | 0.6285 | 0.6285 |
Loa Loa (eye worm) | MaxiK calcium-activated potassium channel | 0.003 | 0.2834 | 0.2834 |
Onchocerca volvulus | Histone deacetylase 10 homolog | 0.0018 | 0 | 0.5 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.004 | 0.4904 | 0.4904 |
Plasmodium falciparum | histone deacetylase 1 | 0.0062 | 1 | 1 |
Trypanosoma cruzi | histone deacetylase 1, putative | 0.0062 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.